Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.7513
+0.0013 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7400
-0.0113 (-1.50%)
After-hours: Sep 18, 2026, 7:05 PM EDT
Akso Health Group Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 6.83 | 7 | 7.84 | 6.93 | 1.52 | 0.89 | 1.32 | 11.86 | - | 0.25 |
Revenue Growth | -12.88% | 0.93% | 415.77% | 676.00% | 14.82% | -92.46% | - | 4721.44% | - | -81.83% |
Gross Profit Gross Profit Growth | -0.63 | 0.62 | -0.47 | 0.19 | 0.08 | 0.04 | 0.14 | 1.13 | - | 0.25 |
Operating Income Operating Income Growth | -2.56 | -1.44 | -3.38 | -0.54 | -6.32 | -2.32 | -14.05 | -0.22 | - | -7.87 |
Net Income Net Income Growth | -17.4 | -1.28 | -134.39 | -0.59 | -6 | -3.46 | -2.17 | 0.81 | - | -8.92 |
Earnings Per Share EPS Growth | -0.02 | -0.00 | -0.40 | -0.00 | -0.10 | -0.15 | -0.11 | 0.03 | - | -0.54 |
EPS Growth | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 0.17 | 11.13 | 176.23 | 91.37 | 85.17 | 9.26 | 7.92 | 9.99 | 18.43 | 15.46 |
Total Debt Total Debt Growth | 2.38 | 2.06 | 2.08 | 6.75 | 2 | 10.04 | 9.69 | 9.69 | 37.2 | 12 |
Net Cash (Debt) Net Cash Growth | -2.21 | 9.07 | 174.15 | 84.62 | 83.17 | -0.77 | -1.76 | 0.3 | -18.77 | 3.46 |
Net Cash Growth | - | -89.29% | 109.38% | - | - | - | - | -91.19% | - | 81.81% |
Net Cash Per Share Net Cash Per Share Growth | -0.00 | 0.02 | 0.52 | 0.36 | 1.16 | -0.03 | -0.08 | 0.01 | - | 0.20 |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -14.02 | 1.23 | 6.02 | -4.85 | 1.11 | 0.24 | -1.92 | -1.33 | - | 0.82 |
Capital Expenditures CapEx Growth | 175.66 | -175.67 | -0.02 | -0.13 | - | - | - | - | - | -10.15 |
Free Cash Flow Free Cash Flow Growth | 161.64 | -174.43 | 6 | -4.98 | 1.11 | 0.24 | -1.92 | -1.33 | - | -9.33 |
Free Cash Flow Growth | 2594.19% | - | 441.04% | - | - | - | - | - | - | - |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
Operating Margin | -37.50% | -20.54% | -43.12% | -7.80% | -415.73% | -259.16% | -1060.54% | -1.86% | - | -3200.11% |
Pretax Margin | -281.92% | -20.57% | -2113.27% | -7.41% | -398.03% | -340.05% | -1111.77% | 13.99% | - | -3618.28% |
Profit Margin | -254.58% | -18.23% | -1713.38% | -8.46% | -394.62% | -386.94% | -163.86% | 6.83% | - | -3625.56% |
FCF Margin | 2365.51% | -2492.40% | 76.49% | -71.77% | 72.92% | 27.12% | -144.90% | -11.25% | - | -3792.01% |
| Fiscal Quarter | H2 2026 | H1 2026 | H2 2025 | H1 2025 | H2 2024 | H1 2024 | H2 2023 | H1 2023 | H2 2022 | H1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Mar '23 Mar 31, 2023 | Sep '22 Sep 30, 2022 | Mar '22 Mar 31, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | 25.61 | - | - |
Forward PE | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 |
P/FCF Ratio | - | - | 415.76 | - | 125.59 | - | - | - | - | - |
PS Ratio | 141.22 | 64.32 | 28.77 | 21.07 | 70.29 | 10.95 | 0.62 | 1.75 | - | 56.32 |